(Q44620414)

4 December 2017

title

Infections with rapidly growing mycobacteria: report of 20 cases (English)

1 reference

nontuberculous mycobacterial infectious disease

4 December 2017

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563223

22 March 2024

author

Somnuek Sungkanuparph

1

object named as

Somnuek Sungkanuparph

1 reference

4 December 2017

author name string

Boonmee Sathapatayavongs

2

1 reference

4 December 2017

Roongnapa Pracharktam

3

1 reference

4 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14563223

22 March 2024

publication date

1 September 2003

1 reference

full work available at URL

4 December 2017

https://doi.org/10.1016/s1201-9712(03)90052-x

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563223

https://api.elsevier.com/content/article/PII:S120197120390052X?httpAccept=text/xml

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1201-9712(03)90052-X

https://api.elsevier.com/content/article/PII:S120197120390052X?httpAccept=text/plain

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1201-9712(03)90052-X

International Journal of Infectious Diseases

22 March 2024

published in

1 reference

4 December 2017

volume

7

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

198-205

1 reference

Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Non-tuberculous mycobacterial lymphadenitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Mycobacterium fortuitum presenting as an asymptomatic enlarging pulmonary nodule

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Pulmonary disease caused by rapidly growing mycobacteria in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Mycobacterial infections in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Nontuberculous mycobacterial keratitis in south Florida.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Non-tuberculous mycobacterial keratitis: a study of 22 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Mycobacterium chelonae keratitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Endogenous Mycobacterium chelonae endophthalmitis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Mycobacterium chelonaeCausing Otitis Media in an Ear-Nose-and-Throat Practice

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Mycobacterium fortuitum mastoiditis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheters

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Disseminated visceral infection with Mycobacterium fortuitum in a hemodialysis patient

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Disseminated infection with rapidly growing mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Diagnosis and treatment of disease caused by nontuberculous mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Sweet's syndrome associated with non-tuberculous mycobacterial infection: a report of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Mycobacterium chelonei keratitis after radial keratotomy

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Postoperative mycobacterial endophthalmitis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

In Vitro Susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to Amikacin

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990052-X

7 January 2021

Spectrum of Disease Due to Rapidly Growing Mycobacteria

1

1 reference

https://api.crossref.org/works/10.1016/S1201-9712(03)90052-X

Chronic otitis media after tympanostomy tube placement caused by Mycobacterium abscessus: a new clinical entity?

22 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/S1201-9712(03)90052-X

Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria

22 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/S1201-9712(03)90052-X

22 March 2024

Identifiers

1 reference

4 December 2017

1 reference